1. Quinine Enhances Photo-Inactivation of Gram-Negative Bacteria.
- Author
-
Leanse LG, Dong PT, Goh XS, Lu M, Cheng JX, Hooper DC, and Dai T
- Subjects
- Acinetobacter Infections microbiology, Acinetobacter baumannii physiology, Animals, Anti-Bacterial Agents pharmacology, Biofilms drug effects, Biofilms radiation effects, Drug Resistance, Multiple, Bacterial drug effects, Drug Resistance, Multiple, Bacterial radiation effects, Female, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Plankton microbiology, Pseudomonas aeruginosa physiology, Quinine pharmacology, Skin injuries, Skin microbiology, Skin pathology, Treatment Outcome, Wounds and Injuries microbiology, Acinetobacter Infections drug therapy, Acinetobacter baumannii drug effects, Acinetobacter baumannii radiation effects, Anti-Bacterial Agents therapeutic use, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa radiation effects, Quinine therapeutic use, Ultraviolet Therapy methods
- Abstract
Background: Antimicrobial resistance is a significant concern to public health, and there is a pressing need to develop novel antimicrobial therapeutic modalities., Methods: In this study, we investigated the capacity for quinine hydrochloride (Q-HCL) to enhance the antimicrobial effects of antimicrobial blue light ([aBL] 405 nm wavelength) against multidrug-resistant (MDR) Gram-negative bacteria in vitro and in vivo., Results: Our findings demonstrated the significant improvement in the inactivation of MDR Pseudomonas aeruginosa and Acinetobacter baumannii (planktonic cells and biofilms) when aBL was illuminated during Q-HCL exposure. Furthermore, the addition of Q-HCL significantly potentiated the antimicrobial effects of aBL in a mouse skin abrasion infection model. In addition, combined exposure of aBL and Q-HCL did not result in any significant apoptosis when exposed to uninfected mouse skin., Conclusions: In conclusion, aBL in combination with Q-HCL may offer a novel approach for the treatment of infections caused by MDR bacteria., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF